Cemdisiran, a potential new drug for the treatment of generalized myasthenia gravis, has been accepted for priority review by ...

New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with ...

InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...

A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...

Investors are betting that a deeper understanding of the brain will allow BCI systems to address the significant unmet need affecting millions of people with neurological disorders. They are also ...

Detailed price information for China Medical System Holdings Ltd (CHSYF) from The Globe and Mail including charting and trades.

Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with Nuvectis, a U.S. biotechnology company. Under the agreement, Haisco ...

Cemdisiran could be the first siRNA approved for the treatment of gMG and only therapy to be offered subcutaneously with four times a year dosing ...

Summary: Patients surviving severe traumatic brain injuries often enter states designated as Prolonged Disorders of ...

In 1939, he repeatedly placed dog ticks on guinea pigs and watched something change. After the first round of bites, the ...

For families facing a pediatric brain or spine condition, access to specialized care can make all the difference. At Driscoll ...

CAMBRIDGE, Mass., July 2, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics ...